- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
LAVA Therapeutics NV (LVTX)
NASDAQ
Currency in USD
Disclaimer
1.650
+0.050(+3.13%)
Closed
After Hours
1.680+0.030(+1.82%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.600
1.650
52 wk Range
1.131
6.470
LVTX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
LAVA Therapeutics NV stock price live, this page displays NASDAQ LVTX stock exchange data. View the LVTX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the LAVA Therapeutics NV real time stock price chart below.
What Is the LAVA Therapeutics NV Stock Price Today?
The LAVA Therapeutics NV stock price today is 1.650.
What Is the Stock Symbol for LAVA Therapeutics NV?
The stock ticker symbol for LAVA Therapeutics NV is LVTX.
Is LVTX the Same as $LVTX?
$LVTX is a common way to refer to the LAVA Therapeutics NV ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does LAVA Therapeutics NV Trade On?
LAVA Therapeutics NV is listed and trades on the NASDAQ stock exchange.
Is LAVA Therapeutics NV a Good Stock to Buy?
Determining whether LAVA Therapeutics NV—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current LAVA Therapeutics NV share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LVTX quote. (ISIN: NL0015000AG6)
What Is the LAVA Therapeutics NV Stock Price Today?
The LAVA Therapeutics NV stock price today is 1.650.
What Is the Stock Symbol for LAVA Therapeutics NV?
The stock ticker symbol for LAVA Therapeutics NV is LVTX.
Is LVTX the Same as $LVTX?
$LVTX is a common way to refer to the LAVA Therapeutics NV ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does LAVA Therapeutics NV Trade On?
LAVA Therapeutics NV is listed and trades on the NASDAQ stock exchange.
Is LAVA Therapeutics NV a Good Stock to Buy?
Determining whether LAVA Therapeutics NV—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current LAVA Therapeutics NV share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LVTX quote. (ISIN: NL0015000AG6)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.6001.650
52 wk Range
1.1316.470
UnlockLVTX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Price Target
6.641
Upside
+302.485%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Lava Therapeutics shares hold target with Buy rating
- Investing.com
- Lava Therapeutics shares hold target with Buy rating
- Investing.com
InvestingPro Research for LAVA Therapeutics NV
Market Valuation | Analysts set a $6 price target, suggesting significant upside potential given the company's current negative enterprise value of approximately $39 million |
Strategic Alliances | Delve into Lava's partnership with Pfizer, showcasing the potential of its technology platform and providing additional financial resources for development |
Pipeline Progress | Explore LAVA-1207's potential in prostate cancer treatment, with upcoming data presentation at SITC conference as a potential catalyst for stock performance |
Oncology Innovato | Lava Therapeutics advances gamma-delta T cell engagers for cancer treatment, with promising clinical trials and a strong cash position of $86.8 million |
LAVA Therapeutics NV Company Profile
LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer patients. Its lead clinical-stage candidates are LAVA-1207 that is in Phase 1/2a clinical trial for metastatic castration-resistant prostate cancer. The company is developing other Gammabody drug candidates, which include LAVA-1223, which targets the epidermal growth factor receptor (EGFR) for the treatment of selected solid tumors, as well as LAVA-1266 which are preclinical candidates for the treatment of various hematologic malignancies. LAVA Therapeutics N.V. has a research collaboration and license agreement with Janssen Biotech, Inc. for the potential discovery and development of multi-specific antibody products that are directed to a specified target in various fields of use; and a collaboration with Merck & Co., Inc. to evaluate anti-PD-1 therapy KEYTRUDA in combination with LAVA-1207. LAVA Therapeutics N.V. was incorporated in 2016 and is headquartered in Utrecht, the Netherlands.
Compare LVTX to Peers and Sector
Metrics to compare | LVTX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLVTXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.8x | −2.3x | −0.6x | |
PEG Ratio | −0.04 | −0.06 | 0.00 | |
Price / Book | 1.0x | 0.6x | 2.6x | |
Price / LTM Sales | 5.9x | 2.1x | 3.2x | |
Upside (Analyst Target) | 264.8% | 87.7% | 43.9% | |
Fair Value Upside | Unlock | 23.2% | 7.8% | Unlock |
People Also Watch
FAQ
What Is the LAVA Therapeutics NV (LVTX) Stock Price Today?
The LAVA Therapeutics NV stock price today is 1.65
What Stock Exchange Does LAVA Therapeutics NV Trade On?
LAVA Therapeutics NV is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for LAVA Therapeutics NV?
The stock symbol for LAVA Therapeutics NV is "LVTX."
What Is the LAVA Therapeutics NV Market Cap?
As of today, LAVA Therapeutics NV market cap is 43.39M.
What is LAVA Therapeutics NV Earnings Per Share?
The LAVA Therapeutics NV EPS is -0.896.
What Is the Next LAVA Therapeutics NV Earnings Date?
LAVA Therapeutics NV will release its next earnings report on Nov 13, 2024.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.